Geriatrics

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes

FDA Alerts

FDA Alert
older patient and younger individual holding hands
FDA Alert
FDA Approves Auvelity for Agitation in Alzheimer Disease Dementia
05/01/2026
Anthony Calabro, MA
The FDA has approved dextromethorphan-bupropion extended-release tablets for agitation associated with Alzheimer disease dementia, offering clinicians a non-antipsychotic treatment option supported by...
05/01/2026
FDA alert
fda
FDA alert
FDA Approves the First RSV Vaccine For Use in United States
05/04/2023
Jessica Ganga
After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.
05/04/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
Osteoporosis
Osteoporosis
FDA Approves New Option for Postmenopausal Osteoporosis
04/09/2019
The FDA has approved a new option for the treatment of osteoporosis in postmenopausal women who have a high risk of fracture.
04/09/2019
Gout
Gout
FDA Issues Boxed Warning For Gout Treatment
02/25/2019
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
02/25/2019